Sanofi (SNY) Earnings Call Analysis

NASDAQ · Unknown · Unknown

25/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

25
Sanofi (SNY) Q2 2026: Launch Portfolio Grows 60%, Elevating 2030 Sales Ambition
July 30, 2026
21
Sanofi (SNY) Q3 2025: New Launches Drive 41% Sales Surge, Offsetting Vaccine Headwinds
June 16, 2026
22
Sanofi (SNY) Q1 2026: Launch Portfolio Grows 44% as Rare Disease and Immunology Drive Strategic Repositioning
April 23, 2026
23
SNY Q4 2025: New Product Sales Jump 34%, Signaling Pipeline-Driven Growth Trajectory
January 29, 2026
22
Sanofi (SNY) Q2 2025: 10.1% CER Sales Growth Driven by Pharma Launches and Immunology Momentum
July 31, 2025
24
Sanofi (SNY) Q1 2025: Dupixent Drives 20% Growth Amid Pipeline Expansion and Strategic Capital Redeployment
April 25, 2025

Browse all companies